vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $168.4M, roughly 1.7× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 14.1%). Over the past eight quarters, Getty Images Holdings, Inc.'s revenue compounded faster (12.7% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
ESPR vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $282.3M |
| Net Profit | — | $-90.9M |
| Gross Margin | — | 74.8% |
| Operating Margin | 50.6% | -8.5% |
| Net Margin | — | -32.2% |
| Revenue YoY | 143.7% | 14.1% |
| Net Profit YoY | — | -467.6% |
| EPS (diluted) | $0.32 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $282.3M | ||
| Q3 25 | $87.3M | $240.0M | ||
| Q2 25 | $82.4M | $234.9M | ||
| Q1 25 | $65.0M | $224.1M | ||
| Q4 24 | $69.1M | $247.3M | ||
| Q3 24 | $51.6M | $240.5M | ||
| Q2 24 | $73.8M | $229.1M | ||
| Q1 24 | $137.7M | $222.3M |
| Q4 25 | — | $-90.9M | ||
| Q3 25 | $-31.3M | $21.6M | ||
| Q2 25 | $-12.7M | $-34.4M | ||
| Q1 25 | $-40.5M | $-102.6M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | $-29.5M | $-2.5M | ||
| Q2 24 | $-61.9M | $3.7M | ||
| Q1 24 | $61.0M | $13.6M |
| Q4 25 | — | 74.8% | ||
| Q3 25 | — | 73.2% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.1% | ||
| Q4 24 | — | 73.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 72.5% | ||
| Q1 24 | — | 72.9% |
| Q4 25 | 50.6% | -8.5% | ||
| Q3 25 | -11.4% | 18.8% | ||
| Q2 25 | 8.6% | 15.1% | ||
| Q1 25 | -34.0% | 12.2% | ||
| Q4 24 | -6.4% | 14.5% | ||
| Q3 24 | -31.0% | 23.9% | ||
| Q2 24 | 3.5% | 20.3% | ||
| Q1 24 | 52.5% | 18.5% |
| Q4 25 | — | -32.2% | ||
| Q3 25 | -35.9% | 9.0% | ||
| Q2 25 | -15.4% | -14.6% | ||
| Q1 25 | -62.2% | -45.8% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | -57.2% | -1.1% | ||
| Q2 24 | -83.9% | 1.6% | ||
| Q1 24 | 44.3% | 6.1% |
| Q4 25 | $0.32 | $-0.22 | ||
| Q3 25 | $-0.16 | $0.05 | ||
| Q2 25 | $-0.06 | $-0.08 | ||
| Q1 25 | $-0.21 | $-0.25 | ||
| Q4 24 | $-0.14 | $0.07 | ||
| Q3 24 | $-0.15 | $-0.01 | ||
| Q2 24 | $-0.33 | $0.01 | ||
| Q1 24 | $0.34 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $90.2M |
| Total DebtLower is stronger | — | $1.3B |
| Stockholders' EquityBook value | $-302.0M | $552.5M |
| Total Assets | $465.9M | $3.2B |
| Debt / EquityLower = less leverage | — | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $90.2M | ||
| Q3 25 | $92.4M | $109.5M | ||
| Q2 25 | $86.1M | $110.3M | ||
| Q1 25 | $114.6M | $114.6M | ||
| Q4 24 | $144.8M | $121.2M | ||
| Q3 24 | $144.7M | $109.9M | ||
| Q2 24 | $189.3M | $121.7M | ||
| Q1 24 | $226.6M | $134.2M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $-302.0M | $552.5M | ||
| Q3 25 | $-451.4M | $634.6M | ||
| Q2 25 | $-433.5M | $611.2M | ||
| Q1 25 | $-426.2M | $593.0M | ||
| Q4 24 | $-388.7M | $670.2M | ||
| Q3 24 | $-370.2M | $683.4M | ||
| Q2 24 | $-344.2M | $654.0M | ||
| Q1 24 | $-294.3M | $640.8M |
| Q4 25 | $465.9M | $3.2B | ||
| Q3 25 | $364.0M | $2.6B | ||
| Q2 25 | $347.1M | $2.6B | ||
| Q1 25 | $324.0M | $2.6B | ||
| Q4 24 | $343.8M | $2.6B | ||
| Q3 24 | $314.1M | $2.6B | ||
| Q2 24 | $352.3M | $2.6B | ||
| Q1 24 | $373.1M | $2.6B |
| Q4 25 | — | 2.30× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 2.21× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 2.06× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $20.6M |
| Free Cash FlowOCF − Capex | — | $7.7M |
| FCF MarginFCF / Revenue | — | 2.7% |
| Capex IntensityCapex / Revenue | 0.0% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $20.6M | ||
| Q3 25 | $-4.3M | $22.6M | ||
| Q2 25 | $-31.4M | $6.5M | ||
| Q1 25 | $-22.6M | $15.4M | ||
| Q4 24 | $-35.0M | $39.7M | ||
| Q3 24 | $-35.3M | $10.7M | ||
| Q2 24 | $-7.2M | $46.4M | ||
| Q1 24 | $53.8M | $21.5M |
| Q4 25 | — | $7.7M | ||
| Q3 25 | — | $7.9M | ||
| Q2 25 | — | $-9.6M | ||
| Q1 25 | — | $-322.0K | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | $-35.5M | $-1.8M | ||
| Q2 24 | $-7.3M | $31.1M | ||
| Q1 24 | $53.8M | $7.1M |
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | -4.1% | ||
| Q1 25 | — | -0.1% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | -68.7% | -0.8% | ||
| Q2 24 | -9.9% | 13.6% | ||
| Q1 24 | 39.0% | 3.2% |
| Q4 25 | 0.0% | 4.6% | ||
| Q3 25 | 0.0% | 6.1% | ||
| Q2 25 | 0.0% | 6.9% | ||
| Q1 25 | 0.0% | 7.0% | ||
| Q4 24 | 0.0% | 6.1% | ||
| Q3 24 | 0.3% | 5.2% | ||
| Q2 24 | 0.1% | 6.7% | ||
| Q1 24 | 0.1% | 6.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.59× | ||
| Q1 24 | 0.88× | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
